15 Years of Success
Camber Pharmaceuticals was established in 2007 as the sales and marketing entity for Hetero’s prescription products in the US market. Hetero is one of the world’s largest producers of Active Pharmaceutical Ingredients (APIs) and offers over 300 finished dose pharmaceutical products globally.
During the past 15 years, Camber has grown to offer hundreds of products such as prescription drugs, over-the-counter medicines, and specialty products spanning many therapeutic areas. The company operates multiple warehouses and distribution centers in the United States, with nearly a half million square feet of storage capacity.
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May